U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H42NO5.Na
Molecular Weight 471.6051
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM GLYCODEOXYCHOLATE

SMILES

[Na+].C[C@H](CCC(=O)NCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

InChI

InChIKey=VMSNAUAEKXEYGP-YEUHZSMFSA-M
InChI=1S/C26H43NO5.Na/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3;/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32);/q;+1/p-1/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-;/m1./s1

HIDE SMILES / InChI
Glycodeoxycholic acid (GDCA), a bile acid, is formed in the liver from chenodeoxycholate and glycine. GDCA was one of twenty-five plasma metabolites, which were significantly different among asthma and healthy controls. Besides, GDCA was elevated in patients with acetaminophen-induced acute liver failure (AALF) and was significantly increased in non-surviving AALF patients compared with survivors. Thus GDCA level could serve as a prognostic biomarker for AALF patients.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients.
2014-12
Loss of organic anion transporting polypeptide 1a1 increases deoxycholic acid absorption in mice by increasing intestinal permeability.
2011-12
Effects of pantoprazole in experimental acute pancreatitis.
2010-10-23
Bile acid-induced virulence gene expression of Vibrio parahaemolyticus reveals a novel therapeutic potential for bile acid sequestrants.
2010-10-13
Fatty acid carboxylate- and anionic surfactant-controlled delivery systems that use mesoporous silica supports.
2010-09-03
Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.
2010-06-17
Probiotic agent Saccharomyces boulardii reduces the incidence of lung injury in acute necrotizing pancreatitis induced rats.
2010-05-01
Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs.
2010-05
Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells.
2010-02
Capsaicin reduces tissue damage in experimental acute pancreatitis.
2009-08
Thermodynamics and structure of inclusion compounds of tauro- and glyco-conjugated bile salts and beta-cyclodextrin.
2009-07-07
Bile acids conjugation in human bile is not random: new insights from (1)H-NMR spectroscopy at 800 MHz.
2009-06
Sodium glycodeoxycholate and glycocholate mixed aggregates in gas and solution phases.
2009-05-21
Use of correction factors in mobility shift affinity capillary electrophoresis for weak analyte-ligand interactions.
2009-05
HO-1-u-1 model for screening sublingual drug delivery--influence of pH, osmolarity and permeation enhancer.
2009-03-31
Characterization of the smallest dimeric bile salt hydrolase from a thermophile Brevibacillus sp.
2009-03
Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS.
2009-02
Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?
2009-02
Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
2009-01
Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis.
2009
P-selectin inhibition reduces severity of acute experimental pancreatitis.
2009
Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis.
2009
Determination of intralumenal individual bile acids by HPLC with charged aerosol detection.
2008-12
Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis.
2008-11
Effects of caffeic acid phenethyl ester on pancreatitis in rats.
2008-03
Design and in vitro characterization of buccoadhesive drug delivery system of insulin.
2008-01
Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis.
2008
Effects of enalaprilat on acute necrotizing pancreatitis in rats.
2007-12
Effects of octreotide in acute hemorrhagic necrotizing pancreatitis in rats.
2007-11
Complexation of tauro- and glyco-conjugated bile salts with three neutral beta-CDs studied by ACE.
2007-10
The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution.
2007-09
Effects of the probiotic agent Saccharomyces Boulardii on the DNA damage in acute necrotizing pancreatitis induced rats.
2007-08
Platelet function in acute experimental pancreatitis.
2007-04
Biosynthesis of bile acids in a variety of marine bacterial taxa.
2007-03
Investigation of microencapsulated BSH active lactobacillus in the simulated human GI tract.
2007
Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention.
2006-11
Effects of dual inhibitor of cyclooxygenase and 5-lipoxygenase on acute necrotizing pancreatitis in rats.
2006-09-26
[Bile salts induce differentiation in cultured human normal esophageal mucosal epithelial cells].
2006-09-12
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum.
2006-08
Structure of sodium glycodeoxycholate micellar aggregates from small-angle X-ray scattering and light-scattering techniques.
2006-06-29
Single-step analysis of individual conjugated bile acids in human bile using 1H NMR spectroscopy.
2006-06
High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B.
2006-03
Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and Bsep.
2006-03
Effect of tamoxifen and raloxifene on the conjugation of bile acids with taurine and glycine in ovariectomized rats.
2006-02-21
Effects of omega-3 fatty acids on acute necrotizing pancreatitis in rats.
2006
MMP-9 in serum correlates with the development of pulmonary complications in experimental acute pancreatitis.
2006
Effects of lazaroid U-74389G on acute necrotizing pancreatitis in rats.
2006
Improvement of impaired microcirculation and tissue oxygenation by hemodilution with hydroxyethyl starch plus cell-free hemoglobin in acute porcine pancreatitis.
2006
Bile salts inhibit growth and induce apoptosis of culture human normal esophageal mucosal epithelial cells.
2005-11-07
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.
1998-01
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Glycodeoxycholic acid (GDCA) can induce the increase of MDA and decrease of fluidity of hepatocyte membrane, and finally cause hepatocyte injury. In the presence of GDCA (final concentration of 250 mumol/L), the concentration of hepatocyte MDA of GDCA increased significantly (P < 0.001) and membrane fluidity decreased (P < 0.02) after culture of 1 or 4 hours. ALT was directly related to MDA and fluorescence polarization (P), r was 0.945 and 0.986, respectively.
Name Type Language
J286.892J
Preferred Name English
SODIUM GLYCODEOXYCHOLATE
Common Name English
SODIUM (((3.ALPHA.,5.BETA.,12.ALPHA.,20R)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)AMINO)ACETATE
Systematic Name English
SODIUM N-((3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)AMINOACETATE
Systematic Name English
GLYCINE, N-((3.ALPHA.,5.BETA.,12.ALPHA.)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)-, MONOSODIUM SALT
Systematic Name English
SODIUM GLYCYLDEOXYCHOLATE
Common Name English
N-(3.ALPHA.,12.ALPHA.-DIHYDROXY-24-OXO-5.BETA.-CHOLAN-24-YL)GLYCINE SODIUM SALT
Systematic Name English
(3.ALPHA.,12.ALPHA.-DIHYDROXY-24-OXO-5.BETA.-CHOLAN-24-YLAMINO)ACETIC ACID SODIUM SALT
Systematic Name English
GLYCINE, N-((3.ALPHA.,5.BETA.,12.ALPHA.)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)-, SODIUM SALT (1:1)
Systematic Name English
2-((4R)-4-((1S,2S,11S,16S,5R,7R,10R,14R,15R)-5,16-DIHYDROXY-2,15-DIMETHYLTETRA CYCLO(8.7.0.0(2,7).0(11,15))HEPTADEC-14-YL)PENTANOYLAMINO)ACETIC ACID, SODIUM SALT
Systematic Name English
GLYCODEOXYCHOLIC ACID, SODIUM SALT
Common Name English
N-((3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)AMINOACETATE
Systematic Name English
N-(2-OXO-2-(SODIOOXY)ETHYL)-3.ALPHA.,12.ALPHA.-DIHYDROXY-5.BETA.-CHOLANE-24-AMIDE
Systematic Name English
SODIUM 2-(((4R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-DIHYDROXY-10,13-DIMETHYL-2,3,4,5,6,7,8,9,11,12,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA(A)PHENANTHREN-17-YL)PENTANOYL)AMINO)ACETATE
Systematic Name English
3.ALPHA.,12.ALPHA.-DIHYDROXY-24-(((SODIOOXYCARBONYL)METHYL)AMINO)-5.BETA.-CHOLAN-24-ONE
Systematic Name English
GLYCINE, N-(3.ALPHA.,12.ALPHA.-DIHYDROXY-5.BETA.-CHOLAN-24-OYL)-, MONOSODIUM SALT
Systematic Name English
Code System Code Type Description
FDA UNII
6W76V75MT1
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
CAS
16409-34-0
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
ECHA (EC/EINECS)
240-455-4
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
PUBCHEM
23688465
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
EPA CompTox
DTXSID30936904
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY